Sarah Waliany

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Health Information

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Sarah Waliany, Jessica J Lin
Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion-Positive Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sarah Waliany, Jessica J Lin
Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion-Positive Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Sarah Waliany, Jessica J Lin
Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion-Positive Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Sarah Waliany, Jessica J Lin
Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion-Positive Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Darryl Leong, Francisco X Galdos, Daniel Lee, Sarah Waliany, Yuhsin Vivian Huang, Julia Ryan, Katherine Dang, Joel W Neal, Heather A Wakelee, Sunil A Reddy, Sandy Srinivas, Lih-Ling Lin, Ronald M Witteles, Holden T Maecker, Mark M Davis, Patricia K Nguyen, Sean M Wu
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis. Circulation 146 (4) (2022)